The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Sarcopenia Treatments Market Research Report 2025
Synopsis
Sarcopenia is a syndrome caused by continuous loss of skeletal muscle mass, strength, and function.
The global Sarcopenia Treatments market was valued at US$ 2762.8 million in 2023 and is anticipated to reach US$ 3799.2 million by 2030, witnessing a CAGR of 4.6% during the forecast period 2024-2030.
China is the largest consumption region of Sarcopenia Treatment, with market share nearly 30.83%. The second largest market is United States; following China with the market share of 24.48%.
This report aims to provide a comprehensive presentation of the global market for Sarcopenia Treatments, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sarcopenia Treatments.
Report Scope
The Sarcopenia Treatments market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sarcopenia Treatments market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sarcopenia Treatments companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Nestlé
Pfizer
Amway
By-health
Usana
A&Z Pharmaceutical
GlaxoSmithKline
Bayer
H&H
Blackmores
Zhendong Group
Segment by Type
Protein Supplement
Calcium Supplement
Other
Segment by Application
Online Pharmacies
Retail Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sarcopenia Treatments companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Sarcopenia is a syndrome caused by continuous loss of skeletal muscle mass, strength, and function.
The global Sarcopenia Treatments market was valued at US$ 2762.8 million in 2023 and is anticipated to reach US$ 3799.2 million by 2030, witnessing a CAGR of 4.6% during the forecast period 2024-2030.
China is the largest consumption region of Sarcopenia Treatment, with market share nearly 30.83%. The second largest market is United States; following China with the market share of 24.48%.
This report aims to provide a comprehensive presentation of the global market for Sarcopenia Treatments, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sarcopenia Treatments.
Report Scope
The Sarcopenia Treatments market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sarcopenia Treatments market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sarcopenia Treatments companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Nestlé
Pfizer
Amway
By-health
Usana
A&Z Pharmaceutical
GlaxoSmithKline
Bayer
H&H
Blackmores
Zhendong Group
Segment by Type
Protein Supplement
Calcium Supplement
Other
Segment by Application
Online Pharmacies
Retail Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sarcopenia Treatments companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sarcopenia Treatments Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Protein Supplement
1.2.3 Calcium Supplement
1.2.4 Other
1.3 Market by Application
1.3.1 Global Sarcopenia Treatments Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Online Pharmacies
1.3.3 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sarcopenia Treatments Market Perspective (2019-2030)
2.2 Sarcopenia Treatments Growth Trends by Region
2.2.1 Global Sarcopenia Treatments Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Sarcopenia Treatments Historic Market Size by Region (2019-2024)
2.2.3 Sarcopenia Treatments Forecasted Market Size by Region (2025-2030)
2.3 Sarcopenia Treatments Market Dynamics
2.3.1 Sarcopenia Treatments Industry Trends
2.3.2 Sarcopenia Treatments Market Drivers
2.3.3 Sarcopenia Treatments Market Challenges
2.3.4 Sarcopenia Treatments Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sarcopenia Treatments Players by Revenue
3.1.1 Global Top Sarcopenia Treatments Players by Revenue (2019-2024)
3.1.2 Global Sarcopenia Treatments Revenue Market Share by Players (2019-2024)
3.2 Global Sarcopenia Treatments Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sarcopenia Treatments Revenue
3.4 Global Sarcopenia Treatments Market Concentration Ratio
3.4.1 Global Sarcopenia Treatments Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sarcopenia Treatments Revenue in 2023
3.5 Sarcopenia Treatments Key Players Head office and Area Served
3.6 Key Players Sarcopenia Treatments Product Solution and Service
3.7 Date of Enter into Sarcopenia Treatments Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sarcopenia Treatments Breakdown Data by Type
4.1 Global Sarcopenia Treatments Historic Market Size by Type (2019-2024)
4.2 Global Sarcopenia Treatments Forecasted Market Size by Type (2025-2030)
5 Sarcopenia Treatments Breakdown Data by Application
5.1 Global Sarcopenia Treatments Historic Market Size by Application (2019-2024)
5.2 Global Sarcopenia Treatments Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Sarcopenia Treatments Market Size (2019-2030)
6.2 North America Sarcopenia Treatments Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Sarcopenia Treatments Market Size by Country (2019-2024)
6.4 North America Sarcopenia Treatments Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sarcopenia Treatments Market Size (2019-2030)
7.2 Europe Sarcopenia Treatments Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Sarcopenia Treatments Market Size by Country (2019-2024)
7.4 Europe Sarcopenia Treatments Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sarcopenia Treatments Market Size (2019-2030)
8.2 Asia-Pacific Sarcopenia Treatments Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Sarcopenia Treatments Market Size by Region (2019-2024)
8.4 Asia-Pacific Sarcopenia Treatments Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sarcopenia Treatments Market Size (2019-2030)
9.2 Latin America Sarcopenia Treatments Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Sarcopenia Treatments Market Size by Country (2019-2024)
9.4 Latin America Sarcopenia Treatments Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sarcopenia Treatments Market Size (2019-2030)
10.2 Middle East & Africa Sarcopenia Treatments Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Sarcopenia Treatments Market Size by Country (2019-2024)
10.4 Middle East & Africa Sarcopenia Treatments Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Sarcopenia Treatments Introduction
11.1.4 Abbott Laboratories Revenue in Sarcopenia Treatments Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Nestlé
11.2.1 Nestlé Company Detail
11.2.2 Nestlé Business Overview
11.2.3 Nestlé Sarcopenia Treatments Introduction
11.2.4 Nestlé Revenue in Sarcopenia Treatments Business (2019-2024)
11.2.5 Nestlé Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Sarcopenia Treatments Introduction
11.3.4 Pfizer Revenue in Sarcopenia Treatments Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 Amway
11.4.1 Amway Company Detail
11.4.2 Amway Business Overview
11.4.3 Amway Sarcopenia Treatments Introduction
11.4.4 Amway Revenue in Sarcopenia Treatments Business (2019-2024)
11.4.5 Amway Recent Development
11.5 By-health
11.5.1 By-health Company Detail
11.5.2 By-health Business Overview
11.5.3 By-health Sarcopenia Treatments Introduction
11.5.4 By-health Revenue in Sarcopenia Treatments Business (2019-2024)
11.5.5 By-health Recent Development
11.6 Usana
11.6.1 Usana Company Detail
11.6.2 Usana Business Overview
11.6.3 Usana Sarcopenia Treatments Introduction
11.6.4 Usana Revenue in Sarcopenia Treatments Business (2019-2024)
11.6.5 Usana Recent Development
11.7 A&Z Pharmaceutical
11.7.1 A&Z Pharmaceutical Company Detail
11.7.2 A&Z Pharmaceutical Business Overview
11.7.3 A&Z Pharmaceutical Sarcopenia Treatments Introduction
11.7.4 A&Z Pharmaceutical Revenue in Sarcopenia Treatments Business (2019-2024)
11.7.5 A&Z Pharmaceutical Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Detail
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Sarcopenia Treatments Introduction
11.8.4 GlaxoSmithKline Revenue in Sarcopenia Treatments Business (2019-2024)
11.8.5 GlaxoSmithKline Recent Development
11.9 Bayer
11.9.1 Bayer Company Detail
11.9.2 Bayer Business Overview
11.9.3 Bayer Sarcopenia Treatments Introduction
11.9.4 Bayer Revenue in Sarcopenia Treatments Business (2019-2024)
11.9.5 Bayer Recent Development
11.10 H&H
11.10.1 H&H Company Detail
11.10.2 H&H Business Overview
11.10.3 H&H Sarcopenia Treatments Introduction
11.10.4 H&H Revenue in Sarcopenia Treatments Business (2019-2024)
11.10.5 H&H Recent Development
11.11 Blackmores
11.11.1 Blackmores Company Detail
11.11.2 Blackmores Business Overview
11.11.3 Blackmores Sarcopenia Treatments Introduction
11.11.4 Blackmores Revenue in Sarcopenia Treatments Business (2019-2024)
11.11.5 Blackmores Recent Development
11.12 Zhendong Group
11.12.1 Zhendong Group Company Detail
11.12.2 Zhendong Group Business Overview
11.12.3 Zhendong Group Sarcopenia Treatments Introduction
11.12.4 Zhendong Group Revenue in Sarcopenia Treatments Business (2019-2024)
11.12.5 Zhendong Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
